RM
Richard Moreau
European Foundation for the Study of Chronic Liver Failure, Travessera de Gràcia, Barcelone, Espagne, INSERM, INSERM and University Paris Diderot
0000-0003-0862-403X
Employment
-
European Foundation for the Study of Chronic Liver Failure, Travessera de Gràcia, Barcelone, Espagne Directeur2024 - Present
-
European Foundation for the Study of Chronic Liver Failure Chairman of the Scientific Advisory Board2019 - 2023
-
INSERM Directeur de Recherche (DRCE) Emérite2018 - Present
Education
-
INSERM and University Paris Diderot MD
Projects & Funding
Projects & funding information is unavailable.
Publications (531)
- Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies. Save
- Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation. Save
- Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis. Save
- Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis. Save
- Interaction of inflammation and portal hypertension in cirrhosis progression. Save
- An editorial on "Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation" by Hong et al. Title: Human cytomegalovirus reactivation in decompensated cirrhosis: marker of immunosuppression or contributor to severity? Save
- Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis. Save
- Defining Organ Failures in Patients With Cirrhosis: Consensus Statements. Save
- The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis. Save
- Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults. Save